Pneumonia death rate lower among people who take statins

Apr 05, 2011

Taking statins could help prevent people dying from pneumonia, according to a study by the London School of Hygiene and Tropical Medicine.

The researchers found that the risk of death in the six month period after diagnosis of pneumonia was substantially lower among those who were already receiving the cholesterol-lowering drugs compared with those who were not.

Previous studies have suggested that statins may be associated with a more favourable outcome after .

This study, published online in the BMJ today, supports a possible protective effect of statins against mortality in patients with pneumonia.

But the researchers point out that as they looked at patients who were already taking the medication when they developed pneumonia, a randomised clinical trial is needed to determine whether starting a statin at the time of diagnosis has a similar effect

Funded by the Wellcome Trust and the Medical Research Council, the team of epidemiologists used data from The Health Improvement Network (THIN), a database of computerised medical records of doctors' practices in the UK, to identify statin users for the study.

They matched each statin user, who were aged over 40 at first prescription of a statin between 1995 and 2006, with up to five non-statin users.

Patients with a record of pneumonia were followed for six months to see if they died and the scientists found that 13% (109 out of 847) of statin users died compared with 20% (578 out of 2927) of non-statin users.

While the study tried to minimise confounding variables, the researchers point out that they cannot rule out the possibility that unknown differences between users and non-users could have contributed to the results.

Lead author Dr Ian Douglas, lecturer in epidemiology at LSHTM, said: "Statins are safe, cheap, and an easy intervention in terms of delivery.

"Given the potential low number needed to treat to prevent a death suggested by this study, we believe that a strong case exists for randomised trials of statins in people with serious infection to determine if a simple and practical intervention at the point of diagnosis of has a beneficial effect."

Explore further: Doctors' checklist could help decrease length of COPD patients' hospital stay

Related Stories

Statins associated with lower risk of death from pneumonia

Oct 27, 2008

Individuals who take cholesterol-lowering statins before being hospitalized with pneumonia appear less likely to die within 90 days afterward, according to a report in the October 27 issue of Archives of Internal Medicine, one of ...

Recommended for you

'Ebola will return', veteran scientist warns

3 hours ago

Congolese expert Jean-Jacques Muyembe may be little known to the public, but he has been one of the world's top Ebola investigators since the first epidemic erupted in central Africa in 1976.

Score IDs patients with upper extremity DVT at low risk

19 hours ago

(HealthDay)—For patients with upper-extremity deep vein thrombosis (DVT), six easily available factors can be used to create a score that identifies those at low risk of adverse events during the first ...

Combined drug treatment combats kidney disease

May 29, 2015

A recent discovery by drug researchers whereby coupling specific cell membrane receptors has altered kidney cell function has triggered a re-think of how to treat chronic kidney disease (CKD) more effectively.

Active substance targeting dreaded hospital germs

May 29, 2015

In the German Center for Infection Research (DZIF), scientists have conducted clinical studies on an active substance against the dreaded hospital pathogen Staphylococcus aureus: a highly effective protein from bacteriophages ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.